Spatial distribution and survival of human and goat mesenchymal stromal cells on hydroxyapatite and β-tricalcium phosphate

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 3, 2016, Pages 233-244

  Prins, Henk Jan ^a   Fernandes, Hugo ^b   Rozemuller, Henk ^a   van Blitterswijk, Clemens ^b   de Boer, Jan ^b   Martens, Anton C M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Bioluminescence imaging; Bone tissue engineering; Hydroxyapatite; Mesenchymal stromal cells; Spatial distribution; tricalcium phosphate

Indexed keywords

BONE; CELL CULTURE; CELL ENGINEERING; CELLS; FLOWCHARTING; HYDROXYAPATITE; PHOSPHORESCENCE; SCAFFOLDS (BIOLOGY); TRANSMISSION CONTROL PROTOCOL;

BIOLUMINESCENCE IMAGING; BONE FORMATION; BONE TISSUE ENGINEERING; CELL-BE; CELL/B.E; CELL/BE; HISTOMORPHOMETRY; MESENCHYMAL STROMAL CELLS; TRI-CALCIUM PHOSPHATES; Β-TRICALCIUM PHOSPHATE;

SPATIAL DISTRIBUTION;

CALCIUM PHOSPHATE; GREEN FLUORESCENT PROTEIN; HYDROXYAPATITE; LENTIVIRUS VECTOR; LUCIFERASE; BETA-TRICALCIUM PHOSPHATE; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BONE TISSUE; CELL CULTURE; CELL EXPANSION; CELL FATE; CELL LABELING; CELL SURVIVAL; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; GOAT; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MESENCHYMAL STROMA CELL; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BAGG ALBINO MOUSE; BONE DEVELOPMENT; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; LUMINESCENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM;

ANIMALS; CALCIUM PHOSPHATES; CELL SURVIVAL; DNA; DURAPATITE; GOATS; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; LUMINESCENT MEASUREMENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; OSTEOGENESIS; TISSUE SCAFFOLDS;

EID: 84961211719     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1681     Document Type: Article

References (59)

1. Agata H, Asahina I, Watanabe N et al. 2010; Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. Tissue Eng Part A 16: 663-673.
2. Albrektsson T, Johansson C. 2001; Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10(suppl 2): S96-101.
3. Baksh D, Song L, Tuan RS. 2004; Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8: 301-316.
4. Blum JS, Barry MA, Mikos AG et al. 2003; In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum Gene Ther 14: 1689-1701.
5. Caplan AI. 1991; Mesenchymal stem cells, J Orthop Res 9: 641-650
6. Caretti V, Zondervan I, Meijer DH et al. 2011; Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model. Brain Pathol 21: 441-451.
7. Chatterjea A, Meijer G, van Blitterswijk C et al. 2010; Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int 2010: 215625.
8. Colter DC, Class R, DiGirolamo CM et al. 2000; Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97: 3213-3218.
9. Colter DC, Sekiya I, Prockop DJ. 2001; Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98: 7841-7845.
10. Contag CH, Bachmann MH. 2002; Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4: 235-260.
11. De Boer J, van Blitterswijk C, Löwik C. 2006; Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 27: 1851-1858.
12. Degano IR, Vilalta M, Bago JR et al. 2008; Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials 29: 427-437.
13. Digirolamo CM, Stokes D, Colter D et al. 1999; Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107: 275-281.
14. Dominici M, Paolucci P, Conte P et al. 2009; Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation 87: S36-42.
15. Fernandes H, Mentink A, Bank R et al. 2010; Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells. Tissue Eng Part A 16: 1693-1702.
16. Friedenstein AJ, Gorskaja JF, Kulagina NN. 1976; Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274.
17. Geuze RE, Everts PA, Kruyt MC et al. 2009; Orthotopic location has limited benefit from allogeneic or autologous multipotent stromal cells seeded on ceramic scaffolds. Tissue Eng Part A 15: 3231-3239.
18. Geuze RE, Prins HJ, Oner FC et al. 2010; Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng Part A 16: 3343-3351.
19. Gronthos S, Zannettino AC, Hay SJ et al. 2003; Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116: 1827-1835.
20. Hardy J, Edinger M, Bachmann MH et al. 2001; Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 29: 1353-1360.
21. Honigman A, Zeira E, Ohana P et al. 2001; Imaging transgene expression in live animals. Mol Ther 4: 239-249.
22. Jiang Y, Jahagirdar BN, Reinhardt RL et al. 2002; Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
23. Klijn RJ, Meijer GJ, Bronkhorst EM et al. 2010; A meta-analysis of histomorphometric results and graft healing time of various biomaterials compared to autologous bone used as sinus floor augmentation material in humans. Tissue Eng Part B Rev 16: 493-507.
24. Kolf CM, Cho E, Tuan RS. 2007; Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9: 204.
25. Kruyt MC, de Bruijn JD, Wilson CE et al. 2003; Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 9: 327-336.
26. Kruyt MC, Persson C, Johansson G et al. 2006; Towards injectable cell-based tissue-engineered bone: the effect of different calcium phosphate microparticles and pre-culturing. Tissue Eng 12: 309-317.
27. Kruyt MC, Dhert WJ, Oner FC et al. 2007; Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 28: 1798-1805.
28. Kuznetsov SA, Krebsbach PH, Satomura K et al. 1997; Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12: 1335-1347.
29. Lee CC, Christensen JE, Yoder MC et al. 2010; Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp Hematol 38: 46-54.
30. Li S, De Wijn JR, Li J et al. 2003; Macroporous biphasic calcium phosphate scaffold with high permeability/porosity ratio. Tissue Eng 9: 535-548.
31. Liu J, Barradas A, Fernandes H et al. 2010; In vitro and in vivo bioluminescent imaging of hypoxia in tissue-engineered grafts. Tissue Eng Part C Methods 16: 479-485.
32. Na IK, Markley JC, Tsai JJ et al. 2010; Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T cell precursors in vivo. Blood 116: e18-25.
33. Olivo C, Alblas J, Verweij V et al. 2008; In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells. J Orthop Res 26: 901-909.
34. Paroo Z, Bollinger RA, Braasch DA et al. 2004; Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3: 117-124.
35. Phinney DG. 2012; Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 13: 2806-2812.
36. Pittenger MF, Mackay AM, Beck SC et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
37. Porada CD, Zanjani ED, Almeida-Porad G. 2006; Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 1: 365-369.
38. Postnov AA, Rozemuller H, Verwey V et al. 2009; Correlation of high-resolution X-ray micro-computed tomography with bioluminescence imaging of multiple myeloma growth in a xenograft mouse model. Calcif Tissue Int 85: 434-443.
39. Prins HJ, Rozemuller H, Vonk-Griffioen S et al. 2009; Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng Part A 15: 3741-3751.
40. Prockop DJ. 1997; Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
41. Quarto R, Mastrogiacomo M, Cancedda R et al. 2001; Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344: 385-386.
42. Rabinovich BA, Ye Y, Etto T et al. 2008; Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci USA 105: 14342-14346.
43. Rozemuller H, van der Spek E, Bogers-Boer LH et al. 2008; A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect. Haematologica 93: 1049-1057.
44. Russell KC, Phinney DG, Lacey MR et al. 2010; In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28: 788-798.
45. Sarugaser R, Hanoun L, Keating A et al. 2009; Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One 4: e6498.
46. Schimming R, Schmelzeisen R. 2004; Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg 62: 724-729.
47. Schop D, Janssen FW, van Rijn LD et al. 2009; Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng Part A 15: 1877-1886.
48. Sekiya I, Larson BL, Smith JR et al. 2002; Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541.
49. Siddappa R, Licht R, van Blitterswijk C et al. 2007; Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25: 1029-1041.
50. Siddappa R, Martens A, Doorn J et al. 2008; cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105: 7281-7286.
51. Song IH, Caplan AI, Dennis JE. 2009; In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res 27: 916-921.
52. Teixeira S, Fernandes H, Leusink A et al. 2010; In vivo evaluation of highly macroporous ceramic scaffolds for bone tissue engineering. J Biomed Mater Res A 93: 567-575.
53. Smith JR, Pochampally R, Perry A et al. 2004; Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 22: 823-831.
54. Wilson-Hench J. 1987; Definitions in biomaterials. In Progress in Biomedical Engineering, Williams DF (ed.). Elsevier: Amsterdam; 29.
55. Wu JC, Sundaresan G, Iyer M et al. 2001; Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 4: 297-306.
56. Würdinger T, Badr C, Pike L et al. 2008; A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 5: 171-173.
57. Yuan H, Van Den Doel M, Li S et al. 2002; A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med 13: 1271-1275.
58. Yuan H, Fernandes H, Habibovic P et al. 2010; Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA 107: 13614-13619.
59. Zuk PA, Zhu M, Mizuno H et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.